← Back to Patent Explorer
US4438261A Expired / Lapsed US ⏱️ 0.0 years remaining

Anticoagulant substance

Assignee: Riker Laboratories Inc
•
Filing: 1982-06-01
•
Granted: 1984-03-20
•
Expires: 2002-06-01
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Partially depolymerized heparin products having particular analyzable reducing end groups, a process for their preparation and their use as anticoagulants and antithrombotics.

Inventors

  • 👤 William E. Barnett

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 01:13
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/70; A61K31/715; C; C08; C08B; C08B37/00; C08B37/006; C08B37/0063; C08B37/0075

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 62 words
A chemically partially depolymerized heparin product which has (1) a weight average molecular weight of from about 2,000 to 4,000 daltons, when determined by HPLC using 1.5 molar aqueous sodium chloride as the mobile phase and dextrans as the standard, (2) a polydispersity (D) of less than about 2.5, and (3) analyzable reducing end groups of which a majority are anhydromannose groups.
Claim 2
Dependent Claim 62 words
A chemically partially depolymerized heparin product which has (1) a weight average molecular weight of from about 2,000 to 4,000 daltons, when determined by HPLC using 1.5 molar aqueous sodium chloride as the mobile phase and dextrans as the standard, (2) a polydispersity (D) of less than about 2.5, and (3) analyzable reducing end groups of which a majority are anhydromannose groups.
Claim 3
Dependent Claim 29 words
A heparin product according to claim 1 wherein the analyzable reducing end groups are selected from anhydromannose, iduronic acid and glucuronic acid of which about 51-90 percent are anhydromannose.
Claim 4
Dependent Claim 21 words
A method for inhibiting the coagulation of which comprises mixing a chemically partially depolymerized heparin according to claim 1 with blood.

References Cited (Backward Citations)

US3766167A Cited
US4303651A Cited
US4281108A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-03-20 1987-09-19 1988-03-20 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-03-20 1991-09-19 1992-03-20 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-03-20 1995-09-19 1996-03-20 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag